Memantine LEK
Land: Den Europæiske Union
Sprog: fransk
Kilde: EMA (European Medicines Agency)
Indlægsseddel
(PIL)
16-11-2020
Produktets egenskaber
(SPC)
16-11-2020
Offentlige vurderingsrapport
(PAR)
29-04-2013
Aktiv bestanddel:
chlorhydrate de mémantine
Tilgængelig fra:
Pharmathen S.A.
ATC-kode:
N06DX01
INN (International Name):
memantine
Terapeutisk gruppe:
Psychoanaleptics, , d'Autres anti-démence médicaments
Terapeutisk område:
Maladie d'Alzheimer
Terapeutiske indikationer:
Traitement des patients atteints de la maladie d'Alzheimer modérée à sévère.
Produkt oversigt:
Revision: 5
Autorisation status:
Autorisé
Autorisation dato:
2013-04-21
Indlægsseddel
Skip to main content [European Medicines Agency]
Menu *
EMA WEBSITE TEMPORARILY UNAVAILABLE
This website is currently unavailable due to essential maintenance.
EMERGENCY CONTACT DETAILS
To report a potentially serious problem with a centrally authorised
medicine, call our product emergency hotline on +31 (0)88 781 7600.
To report a product quality defect, including a suspected defect, of a
centrally authorised medicine that could result in a recall or
abnormal restriction on supply, marketing or manufacturing
authorisation holders can call +31 (0)65 008 9457 outside business
hours.
The details of your call may be documented, including personal data if
you provide them (such as your name, contact details and nature of the
issue raised), in accordance with our privacy statement. You can
consult our privacy statement at
https://www.ema.europa.eu/en/about-us/legal/general-privacy-statement
[/en/about-us/legal/general-privacy-statement] once the website is
back online.
RSS feed Twitter YouTube LinkedIn
© 1995-2020 European Medicines Agency
European Union agencies network [European Union agencies network]
An agency of the European Union [European Union flag]
Læs hele dokumentet
Produktets egenskaber
Skip to main content [European Medicines Agency]
Menu *
EMA WEBSITE TEMPORARILY UNAVAILABLE
This website is currently unavailable due to essential maintenance.
EMERGENCY CONTACT DETAILS
To report a potentially serious problem with a centrally authorised
medicine, call our product emergency hotline on +31 (0)88 781 7600.
To report a product quality defect, including a suspected defect, of a
centrally authorised medicine that could result in a recall or
abnormal restriction on supply, marketing or manufacturing
authorisation holders can call +31 (0)65 008 9457 outside business
hours.
The details of your call may be documented, including personal data if
you provide them (such as your name, contact details and nature of the
issue raised), in accordance with our privacy statement. You can
consult our privacy statement at
https://www.ema.europa.eu/en/about-us/legal/general-privacy-statement
[/en/about-us/legal/general-privacy-statement] once the website is
back online.
RSS feed Twitter YouTube LinkedIn
© 1995-2020 European Medicines Agency
European Union agencies network [European Union agencies network]
An agency of the European Union [European Union flag]
Læs hele dokumentet
